Expertise in
1
conditions

Lai-ping Zhong

Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, 
Shanghai, CN 
Expertise in
1
conditions
Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Lai-ping Zhong practices in Shanghai, China. Zhong is highly rated in 1 condition, according to our data. Their top areas of expertise are Oral Squamous Cell Carcinoma, Hemangiopericytoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Folliculitis.

Their clinical research consists of co-authoring 39 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients: A Single-arm Phase I Trial
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients: A Single-arm Phase I Trial
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Toripalimab, Paclitaxel, Cisplatin
Study Phase: Phase 1
A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma
A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: November 22, 2023
Intervention Type: Radiation, Drug, Procedure
Study Drugs: Docetaxel, Cisplatin
Study Phase: Phase 2
Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I Trial
Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I Trial
Enrollment Status: Completed
Publish Date: April 05, 2023
Intervention Type: Drug
Study Drug: Carrimycin
Study Phase: Phase 1
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: August 21, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

39 Total Publications

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.
Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.
Journal: EClinicalMedicine
Published: June 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhong's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile